Genprex (GNPX) Enterprise Value (2016 - 2025)
Genprex (GNPX) has 10 years of Enterprise Value data on record, last reported at -$1.1 million in Q3 2025.
- For Q3 2025, Enterprise Value rose 25.87% year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$1.1 million, up 25.87%, while the annual FY2024 figure was -$1.6 million, 76.23% up from the prior year.
- Enterprise Value reached -$1.1 million in Q3 2025 per GNPX's latest filing, up from -$1.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q3 2025 and bottomed at -$47.1 million in Q1 2021.
- Average Enterprise Value over 5 years is -$18.4 million, with a median of -$11.7 million recorded in 2023.
- Peak YoY movement for Enterprise Value: tumbled 103.94% in 2021, then surged 87.29% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$38.6 million in 2021, then skyrocketed by 45.76% to -$21.0 million in 2022, then skyrocketed by 67.85% to -$6.7 million in 2023, then soared by 76.23% to -$1.6 million in 2024, then soared by 31.11% to -$1.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$1.1 million in Q3 2025, -$1.3 million in Q2 2025, and -$3.5 million in Q1 2025.